NCT05256264

Brief Summary

Ketamine is widely used in the setting of multimodal general anesthesia, and the Electroencephalographic density spectral array (DSA) monitoring has been implemented in the practice of anesthesia. The purpose of this study is to investigate the dose-response EEG changes in patients during the perioperative period when ketamine is used. With the application of machine-learning algorithm, we aim to interpret the ketamine dosing precisely and accurately, based on the DSA obtained.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

August 17, 2022

Status Verified

August 1, 2022

Enrollment Period

10 months

First QC Date

February 15, 2022

Last Update Submit

August 15, 2022

Conditions

Keywords

General anesthesiaKetamineDensity Spectrum ArrayElectroencephalogramMultimodal General AnesthesiaMachine learning

Outcome Measures

Primary Outcomes (1)

  • Ketamine dosing based on EEG DSA

    The DSA is obtained from raw EEG by fast Fourier transformation. By interpreting the DSA, we can obtain the trends and changes of power within different frequencies over time, in respect to different ketamine dosing.

    DSA EEG is placed before anesthesia starts, recorded throughout the operative procedure until emergence and patient is extubated. The saved EEG DSA data will be retrieved by the end of the day.

Study Arms (3)

Control group

Sevoflurane

Low dose ketamine group

Sevoflurane + 3µg/kg/min ketamine infusion

Drug: Ketamine

High dose ketamine group

Sevoflurane + 6µg/kg/min ketamine infusion

Drug: Ketamine

Interventions

Ketamine infusion at different dose to observe EEG DSA changes

Also known as: Ketamine Hydrochloride
High dose ketamine groupLow dose ketamine group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted for spine surgery under the department of orthopedic surgery at VGHTPE, a tertiary hospital in Taiwan, will be selected.

You may qualify if:

  • Patients undergoing elective spine surgery
  • Aged 20-80 years old

You may not qualify if:

  • Pregnancy
  • Presence of major brain disorders: stroke, epilepsy, Parkinson's disease, etc.
  • Any of the following major organ disorders:
  • Chronic pulmonary disease (Clinically diagnosed severe chronic obstructive pulmonary disease or FEV1/FVC \<70% or FEV1 \<50%)
  • Heart failure (NYHA III or IV)
  • Chronic renal failure (eGFR\<60ml/min/1.73m2)
  • Ongoing sepsis or infection
  • Ongoing of history of CNS-acting medications/substances use (e.g.: sedatives, hypnotics, stimulants, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, Beitou, 112, Taiwan

RECRUITING

MeSH Terms

Interventions

Ketamine

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Chien-Kun Ting, MD, PhD

    Taipei Veterans General Hospital, Taiwan

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2022

First Posted

February 25, 2022

Study Start

March 1, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

August 17, 2022

Record last verified: 2022-08

Locations